Friday, October 12, 2012

• Sanofi Aims to Add Second-Generation Lemtrada to Pipelineat Bloomberg (Fri, Oct 12)

Monday, October 8, 2012

• Toddlers Facing Heart Attacks Await Ruling on New Drugsat Bloomberg (Mon, Oct 8)
• Lilly Backs Broad Diabetes Range to Challenge Rivalsat Bloomberg (Mon, Oct 8)

Thursday, October 4, 2012

• Sanofi Defends Lyxumia Under Scrutiny at Diabetes Meetingat Bloomberg (Thu, Oct 4)

Wednesday, October 3, 2012

• Bristol-Myers Returns Sanofi Drug Rights as Patents Expireat Bloomberg (Wed, Oct 3)
• European Stocks Drop as Spain Damps Bailout Speculationat Bloomberg (Wed, Oct 3)

Monday, October 1, 2012

• Novartis Banks on Meningitis Shot to Justify ‘Oops’ Dealat Bloomberg (Mon, Oct 1)

Sunday, September 30, 2012

• Pfizer Lung Cancer Drug Doubles Benefit, Researchers Sayat Bloomberg (Sun, Sep 30)

Thursday, September 27, 2012

• J%J Pushed Risperdal With Golf, Popcorn, Witness Saysat Bloomberg (Thu, Sep 27)

Wednesday, September 26, 2012

• Dual Multiple Sclerosis Finding May Change Therapyat Bloomberg (Wed, Sep 26)

Tuesday, September 25, 2012

• Sanofi Plans 900 Job Cuts Amid French Research Overhaulat Bloomberg (Tue, Sep 25)

Friday, September 21, 2012

• Carfilzomib Approved for Myeloma Therapy, Hepatitis C Treatments, Colorectal Cancer Drug Regorafenib Receives Approval, Phase III Trials for Hsp90 Inhibitor: Medical Breakthroughs are Powering Biotech Sector HigherWall Street Transcript (Fri, Sep 21)
• Sanofi, Kweichow Moutai, Microsoft: Intellectual Propertyat Bloomberg (Fri, Sep 21)

Thursday, September 20, 2012

• Sanofi Bid to Block Generic Aprovel Goes to EU Courtsat Bloomberg (Thu, Sep 20)
• Dingell, Alito, Barney Frank, Olympia Snowe, J.D. Powerat Bloomberg (Thu, Sep 20)

Tuesday, September 18, 2012

• J&J Centers to Look for Acquisition, Licensing Dealsat Bloomberg (Tue, Sep 18)

Monday, September 17, 2012

• French S&P Downgrade Was Upgrade in Investor Repudiationat Bloomberg (Mon, Sep 17)

Thursday, September 13, 2012

• Sanofi Wins U.S. FDA Approval for Multiple Sclerosis Pillat Bloomberg (Thu, Sep 13)
• J&J’s Bengay, Sanofi’s Icy Hot May Cause Rare Burns, FDA Saysat Bloomberg (Thu, Sep 13)
• Whooping Cough Vaccine Loses Strength After Fifth Doseat Bloomberg (Thu, Sep 13)

Wednesday, September 12, 2012

• Sanofi CEO Sees Opportunities for Deals in Vietnam, Colombiaat Bloomberg (Wed, Sep 12)

Tuesday, September 4, 2012

• European Stocks Decline on U.S. Manufacturing Reportat Bloomberg (Tue, Sep 4)

Monday, August 27, 2012

• Bayer’s Xarelto Helped Survival After Heart Attack: Studyat Bloomberg (Mon, Aug 27)

Saturday, August 25, 2012

• Boehringer, Bayer Blood Thinners Backed for Arrhythmiaat Bloomberg (Sat, Aug 25)

Wednesday, August 22, 2012

• Bavarian Nordic at Risk as U.S. Weighs Smallpox Orderat Bloomberg (Wed, Aug 22)

Add SAN.PA News to My Yahoo!